India’s copycat drugmakers gear up to offer cheaper weight-loss drugs

Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic

Read More from the Global Wellness News ™

Save Your Cart
Share Your Cart